Last updated on March 2020

A Study to Evaluate Risankizumab in Adult and Adolescent Subjects With Moderate to Severe Atopic Dermatitis

Brief description of study

The purpose of this study is to assess the safety and efficacy of risankizumab for the treatment of moderate to severe atopic dermatitis (AD) in adult and adolescent subjects.

Clinical Study Identifier: NCT03706040

Find a site near you

Start Over

Dundee Dermatology /ID# 212505

West Dundee, IL United States
  Connect »

DermAssociates /ID# 206189

Rockville, MD United States
  Connect »

RI SkinDoc /ID# 203417

Johnston, RI United States
  Connect »

Health Concepts /ID# 203205

Rapid City, SD United States
  Connect »

Acclaim Dermatology /ID# 213026

Sugar Land, TX United States
  Connect »

Darst Dermatology /ID# 215100

Charlotte, NC United States
  Connect »

Tulane Univ /ID# 203214

New Orleans, LA United States
  Connect »

Unity Clinical Research /ID# 217461

Oklahoma City, OK United States
  Connect »